A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

May 31, 2010

Study Completion Date

June 30, 2010

Conditions
Pancreatic Neoplasms
Interventions
DRUG

imexon in combination with gemcitabine

875 mg/m\^2 imexon IV + 1000 mg/m\^2 gemcitabine IV

DRUG

imexon placebo + gemcitabine

imexon placebo IV + 1000 mg/m\^2 gemcitabine IV

Trial Locations (48)

14263

Roswell Park Cancer Institute, Buffalo

15232

University of Pittsburgh Cancer Institute, Pittsburgh

18704

Medical Onc Assoc of Wyoming Valley, PC- US Oncology, Kingston

19013

Associates in Hematology-Oncology P.C. US Oncology, Upland

19111

Fox Chase Cancer Center, Philadelphia

19464

Pottstown Memorial Medical Center, Pottstown

19611

Reading Hospital Regional Medical Center, West Reading

23502

Virginia Oncology Associates- US Oncology, Norfolk

24153

Onc & Hematology Assoc. of Southern VA, Inc D.B.A. - US Oncology, Salem

27607

Cancer Center of North Carolina- US Oncology, Raleigh

30309

Peachtree Hematology and Oncology Consultants, Atlanta

34471

Ocala Oncology Center- US Oncology, Ocala

34761

Cancer Centers of Florida- US Oncology, Orlando

35205

Birmingham Hematology and Oncology- US Oncology, Birmingham

46227

Central Indiana Cancer Centers- US Oncology, Indianapolis

46601

Northern Indiana Cancer Research Consortium, South Bend

47802

Hope Center- US Oncology, Terre Haute

48109

University of Michigan, Ann Arbor

55455

University of Minnesota, Minneapolis

57104

Sanford Clinic, Sioux Falls

60611

Hematology Oncology Associates of Illinois- US Oncology, Chicago

60714

Cancer Care & Hematolog Specialists of Chicagoland- US Oncology, Niles

64131

Kansas City Cancer Center, LLC- US Oncology, Kansas City

75230

Texas Cancer Center at Medical City- US Oncology, Dallas

75231

Texas Oncology P.A. - Dallas- US Oncology, Dallas

75237

Methodist Charlton Cancer Center - Texas Oncology- US Oncology, Dallas

76022

Texas Oncology P.A.- Bedford- US Oncology, Bedford

76310

Texoma Cancer Center- US Oncology, Wichita Falls

76508

Scott and White Hospital and Clinics, Temple

76712

Texas Oncology Cancer Care and Research Center- US Oncology, Waco

77702

Mamie Mcfaddin Ward Cancer Center, Texas Oncology- US Oncology, Beaumont

79106

Texas Oncology - Amarillo- US Oncology, Amarillo

79761

Texas Oncology - Odessa- US Oncology, Odessa

80218

Rocky Mountain Cancer Center- US Oncology, Denver

85704

AZ Onc Associates D.B.A. Hematology Oncology- US Oncology, Tucson

85715

Arizona Clinical Research Center, Tucson

87106

Hematology Oncology Associates, Albuquerque

87131

University of New Mexico, Albuquerque

87505

New Mexico Cancer Care Associates- US Oncology, Santa Fe

88011

University of New Mexico Cancer Center South, Las Cruces

89169

Comprehensive Cancer Centers of Nevada- US Oncology, Las Vegas

98104

Swedish Cancer Institute, Seattle

98684

Northwest Cancer Specialists- US Oncology, Vancouver

99202

Cancer Care Northwest- US Oncology, Spokane

40536-0093

University of Kentucky, Hematology/Oncology/BMT Clinical Research, Lexington

01805

Lahey Clinic, Burlington

08822

Hunterdon Regional Cancer Center, Flemington

08060

Hematology Oncology Associates, Mount Holly

Sponsors
All Listed Sponsors
lead

AmpliMed Corporation

INDUSTRY